Why Attend?
✔️ Expert Insights
✔️ Interactive Discussions
✔️ Networking Opportunities
➡️ Register now: bit.ly/3Na1DZ7
Why Attend?
✔️ Expert Insights
✔️ Interactive Discussions
✔️ Networking Opportunities
➡️ Register now: bit.ly/3Na1DZ7
📃 Programme: bit.ly/3m5gaIQ
👤 Expert panel: bit.ly/44A4Wmi
➡️ Register now: bit.ly/3Na1DZ7
📃 Programme: bit.ly/3m5gaIQ
👤 Expert panel: bit.ly/44A4Wmi
➡️ Register now: bit.ly/3Na1DZ7
What is truly mandatory in assessing co-pathology in #Alzheimer’s disease and what remains optional?
➡️ Join the debate: bit.ly/3Na1DZ7
What is truly mandatory in assessing co-pathology in #Alzheimer’s disease and what remains optional?
➡️ Join the debate: bit.ly/3Na1DZ7
Regulatory approval of #amyloid-lowering #immunotherapies in #Alzheimer’s disease: should clearcut biomarker evidence be the deciding factor?
➡️ Be part of the discussion:
Regulatory approval of #amyloid-lowering #immunotherapies in #Alzheimer’s disease: should clearcut biomarker evidence be the deciding factor?
➡️ Be part of the discussion:
Is #amyloid #positivity sufficient to select patients with #Alzheimer's disease for anti-amyloid treatments? Hear insights from leading experts and join the debate!
➡️ bit.ly/3Na1DZ7
Is #amyloid #positivity sufficient to select patients with #Alzheimer's disease for anti-amyloid treatments? Hear insights from leading experts and join the debate!
➡️ bit.ly/3Na1DZ7
Detection of Amyloid & Tau Pathology
How can #PET, #CSF & #plasma #biomarkers work together to improve #Alzheimer’s diagnosis? Hear insights from leading experts and join the debate on whether plasma markers alone are enough.
➡️ Register now: bit.ly/3Na1DZ7
Detection of Amyloid & Tau Pathology
How can #PET, #CSF & #plasma #biomarkers work together to improve #Alzheimer’s diagnosis? Hear insights from leading experts and join the debate on whether plasma markers alone are enough.
➡️ Register now: bit.ly/3Na1DZ7
⌛ Deadline: 𝟯𝟭 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟱 (𝟮𝟯:𝟱𝟵 𝗖𝗘𝗧)
🔗 Register now and save: bit.ly/3Na1DZ7
⌛ Deadline: 𝟯𝟭 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟱 (𝟮𝟯:𝟱𝟵 𝗖𝗘𝗧)
🔗 Register now and save: bit.ly/3Na1DZ7
Join us in Mallorca, Spain, Feb 5–7, 2026 for #FocusMeeting7!
🎥 Watch the dedicated EANM TV episode to learn more.
Join us in Mallorca, Spain, Feb 5–7, 2026 for #FocusMeeting7!
🎥 Watch the dedicated EANM TV episode to learn more.
🗓️ Dates: February 5-7, 2026
📍 Location: Palma de Mallorca, Spain
📃 Scientific Programme: bit.ly/3m5gaIQ
➡️ Register Now! Spaces are limited to 250 high-level experts: bit.ly/3Na1DZ7
🗓️ Dates: February 5-7, 2026
📍 Location: Palma de Mallorca, Spain
📃 Scientific Programme: bit.ly/3m5gaIQ
➡️ Register Now! Spaces are limited to 250 high-level experts: bit.ly/3Na1DZ7
Learn about breakthroughs in #nuclear #neuroimaging transforming the
landscape of #neurodegenerative diseases at the #EANM #FocusMeeting7
🎟️ Limited spots available: bit.ly/3YH8Y9M
Learn about breakthroughs in #nuclear #neuroimaging transforming the
landscape of #neurodegenerative diseases at the #EANM #FocusMeeting7
🎟️ Limited spots available: bit.ly/3YH8Y9M
📅 𝗗𝗮𝘁𝗲: February 5–7, 2026
📍 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Palma de Mallorca, Spain
🔗 𝗙𝗶𝗻𝗱 𝗼𝘂𝘁 𝗺𝗼𝗿𝗲: bit.ly/3YH8Y9M
Don't miss the conversations shaping the future of #Alzheimer’s care!
📅 𝗗𝗮𝘁𝗲: February 5–7, 2026
📍 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Palma de Mallorca, Spain
🔗 𝗙𝗶𝗻𝗱 𝗼𝘂𝘁 𝗺𝗼𝗿𝗲: bit.ly/3YH8Y9M
Don't miss the conversations shaping the future of #Alzheimer’s care!